Brief: Grand Pharmaceutical Says NDA Of RDC TLX591-CDX Accepted By NMPA
19/01/2026 10:10
Jan 19 (Reuters) - Grand Pharmaceutical 0512.HK: NDA OF RDC TLX591-CDX IS ACCEPTED BY NMPA Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement